Keeler Thomas Management LLC bought a new position in shares of Healthequity Inc (NASDAQ:HQY) in the 4th quarter, Holdings Channel reports. The firm bought 8,900 shares of the company’s stock, valued at approximately $415,000.

A number of other hedge funds have also bought and sold shares of HQY. Ameritas Investment Partners Inc. increased its position in Healthequity by 17.4% during the second quarter. Ameritas Investment Partners Inc. now owns 4,375 shares of the company’s stock worth $218,000 after buying an additional 648 shares during the period. Stifel Financial Corp increased its position in Healthequity by 3.4% during the second quarter. Stifel Financial Corp now owns 38,873 shares of the company’s stock worth $1,916,000 after buying an additional 1,263 shares during the period. Louisiana State Employees Retirement System increased its position in Healthequity by 6.8% during the fourth quarter. Louisiana State Employees Retirement System now owns 22,100 shares of the company’s stock worth $1,031,000 after buying an additional 1,400 shares during the period. Piedmont Investment Advisors LLC increased its position in Healthequity by 15.9% during the third quarter. Piedmont Investment Advisors LLC now owns 11,105 shares of the company’s stock worth $562,000 after buying an additional 1,520 shares during the period. Finally, Fortaleza Asset Management Inc. increased its position in Healthequity by 56.0% during the third quarter. Fortaleza Asset Management Inc. now owns 4,330 shares of the company’s stock worth $219,000 after buying an additional 1,555 shares during the period. Hedge funds and other institutional investors own 98.63% of the company’s stock.

Healthequity Inc (HQY) opened at $51.29 on Monday. Healthequity Inc has a twelve month low of $37.62 and a twelve month high of $55.31. The firm has a market capitalization of $3,111.90, a price-to-earnings ratio of 69.31, a P/E/G ratio of 1.96 and a beta of 1.70.

Healthequity (NASDAQ:HQY) last announced its quarterly earnings data on Tuesday, December 5th. The company reported $0.17 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.13 by $0.04. Healthequity had a return on equity of 14.47% and a net margin of 21.08%. The firm had revenue of $56.80 million for the quarter, compared to analyst estimates of $55.27 million. During the same quarter in the prior year, the company posted $0.10 earnings per share. Healthequity’s quarterly revenue was up 31.0% on a year-over-year basis. research analysts predict that Healthequity Inc will post 0.73 earnings per share for the current fiscal year.

A number of research analysts have recently issued reports on the company. Cantor Fitzgerald boosted their target price on Healthequity from $56.00 to $60.00 and gave the company an “overweight” rating in a report on Wednesday, February 7th. Robert W. Baird boosted their target price on Healthequity from $48.00 to $49.00 and gave the company a “neutral” rating in a report on Wednesday, February 7th. Zacks Investment Research raised Healthequity from a “hold” rating to a “buy” rating and set a $60.00 target price on the stock in a report on Wednesday, November 8th. BidaskClub raised Healthequity from a “sell” rating to a “hold” rating in a report on Tuesday, November 7th. Finally, Chardan Capital boosted their target price on Healthequity from $58.00 to $62.00 and gave the company a “buy” rating in a report on Wednesday, December 6th. Two analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Healthequity currently has a consensus rating of “Buy” and a consensus target price of $56.67.

In related news, Director Frank Medici sold 700 shares of the company’s stock in a transaction on Wednesday, November 15th. The stock was sold at an average price of $51.05, for a total transaction of $35,735.00. Following the transaction, the director now owns 6,381 shares of the company’s stock, valued at $325,750.05. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Darcy G. Mott sold 9,500 shares of the company’s stock in a transaction on Monday, November 20th. The stock was sold at an average price of $49.68, for a total value of $471,960.00. Following the transaction, the vice president now directly owns 93,500 shares in the company, valued at approximately $4,645,080. The disclosure for this sale can be found here. Insiders have sold 371,426 shares of company stock worth $18,749,703 in the last ninety days. 19.00% of the stock is currently owned by corporate insiders.

TRADEMARK VIOLATION WARNING: “Keeler Thomas Management LLC Buys New Position in Healthequity Inc (HQY)” was posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this piece on another website, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this piece can be accessed at https://theolympiareport.com/2018/02/12/keeler-thomas-management-llc-buys-new-position-in-healthequity-inc-hqy.html.

Healthequity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthequity Inc (NASDAQ:HQY).

Institutional Ownership by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.